Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Deciphering genetic interactions between ALS genes using C. elegans.

Therrien M, Parker JA.

Worm. 2014 May 8;3:e29047. doi: 10.4161/worm.29047. eCollection 2014.

2.

MAPT rs242562 and GSK3B rs334558 are associated with Parkinson's Disease in central China.

Yu L, Huang J, Zhai D, Liu L, Guo K, Long X, Xiong J, Zhang Z, Wang Y, Zhao Y, Wu P, Wang D, Lin Z, Wu J, Xiong N, Wang T.

BMC Neurosci. 2014 Apr 29;15:54. doi: 10.1186/1471-2202-15-54.

3.

The role of tau in neurodegenerative diseases and its potential as a therapeutic target.

Wolfe MS.

Scientifica (Cairo). 2012;2012:796024. doi: 10.6064/2012/796024. Epub 2012 Dec 19. Review.

4.

Protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants.

Heckman MG, Elbaz A, Soto-Ortolaza AI, Serie DJ, Aasly JO, Annesi G, Auburger G, Bacon JA, Boczarska-Jedynak M, Bozi M, Brighina L, Chartier-Harlin MC, Dardiotis E, Destée A, Ferrarese C, Ferraris A, Fiske B, Gispert S, Hadjigeorgiou GM, Hattori N, Ioannidis JP, Jasinska-Myga B, Jeon BS, Kim YJ, Klein C, Kruger R, Kyratzi E, Lin CH, Lohmann K, Loriot MA, Lynch T, Mellick GD, Mutez E, Opala G, Park SS, Petrucci S, Quattrone A, Sharma M, Silburn PA, Sohn YH, Stefanis L, Tadic V, Tomiyama H, Uitti RJ, Valente EM, Vassilatis DK, Vilariño-Güell C, White LR, Wirdefeldt K, Wszolek ZK, Wu RM, Xiromerisiou G, Maraganore DM, Farrer MJ, Ross OA; Genetic Epidemiology Of Parkinson's Disease (GEO-PD) Consortium.

Neurobiol Aging. 2014 Jan;35(1):266.e5-14. doi: 10.1016/j.neurobiolaging.2013.07.013. Epub 2013 Aug 17.

5.

GSK3B and MAPT polymorphisms are associated with grey matter and intracranial volume in healthy individuals.

Dobson-Stone C, Polly P, Korgaonkar MS, Williams LM, Gordon E, Schofield PR, Mather K, Armstrong NJ, Wen W, Sachdev PS, Kwok JB.

PLoS One. 2013 Aug 12;8(8):e71750. doi: 10.1371/journal.pone.0071750. eCollection 2013.

6.

Identifying the genetic components underlying the pathophysiology of movement disorders.

Ezquerra M, Compta Y, Marti MJ.

Appl Clin Genet. 2011 Jun 23;4:81-92. doi: 10.2147/TACG.S7333. Print 2011.

7.

Decreased parkin solubility is associated with impairment of autophagy in the nigrostriatum of sporadic Parkinson's disease.

Lonskaya I, Hebron ML, Algarzae NK, Desforges N, Moussa CE.

Neuroscience. 2013 Mar 1;232:90-105. doi: 10.1016/j.neuroscience.2012.12.018. Epub 2012 Dec 20.

8.

Secondary RNA structure and nucleotide specificity contribute to internal initiation mediated by the human tau 5' leader.

Veo BL, Krushel LA.

RNA Biol. 2012 Nov;9(11):1344-60. doi: 10.4161/rna.22181. Epub 2012 Sep 20.

9.

Fractalkine Mediates Communication between Pathogenic Proteins and Microglia: Implications of Anti-Inflammatory Treatments in Different Stages of Neurodegenerative Diseases.

Desforges NM, Hebron ML, Algarzae NK, Lonskaya I, Moussa CE.

Int J Alzheimers Dis. 2012;2012:345472. doi: 10.1155/2012/345472. Epub 2012 Aug 5.

10.

Wild type and P301L mutant Tau promote neuro-inflammation and α-Synuclein accumulation in lentiviral gene delivery models.

Khandelwal PJ, Dumanis SB, Herman AM, Rebeck GW, Moussa CE.

Mol Cell Neurosci. 2012 Jan;49(1):44-53. doi: 10.1016/j.mcn.2011.09.002. Epub 2011 Sep 14.

11.

Inflammation in the early stages of neurodegenerative pathology.

Khandelwal PJ, Herman AM, Moussa CE.

J Neuroimmunol. 2011 Sep 15;238(1-2):1-11. doi: 10.1016/j.jneuroim.2011.07.002. Epub 2011 Aug 5. Review.

12.

The Relationship between Parkin and Protein Aggregation in Neurodegenerative Diseases.

Khandelwal PJ, Moussa CE.

Front Psychiatry. 2010 Jun 3;1:15. doi: 10.3389/fpsyt.2010.00015. eCollection 2010.

13.

Independent and joint effects of the MAPT and SNCA genes in Parkinson disease.

Elbaz A, Ross OA, Ioannidis JP, Soto-Ortolaza AI, Moisan F, Aasly J, Annesi G, Bozi M, Brighina L, Chartier-Harlin MC, Destée A, Ferrarese C, Ferraris A, Gibson JM, Gispert S, Hadjigeorgiou GM, Jasinska-Myga B, Klein C, Krüger R, Lambert JC, Lohmann K, van de Loo S, Loriot MA, Lynch T, Mellick GD, Mutez E, Nilsson C, Opala G, Puschmann A, Quattrone A, Sharma M, Silburn PA, Stefanis L, Uitti RJ, Valente EM, Vilariño-Güell C, Wirdefeldt K, Wszolek ZK, Xiromerisiou G, Maraganore DM, Farrer MJ; Genetic Epidemiology of Parkinson's Disease (GEO-PD) Consortium.

Ann Neurol. 2011 May;69(5):778-92. doi: 10.1002/ana.22321. Epub 2011 Mar 9.

14.

Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease.

Edwards TL, Scott WK, Almonte C, Burt A, Powell EH, Beecham GW, Wang L, Züchner S, Konidari I, Wang G, Singer C, Nahab F, Scott B, Stajich JM, Pericak-Vance M, Haines J, Vance JM, Martin ER.

Ann Hum Genet. 2010 Mar;74(2):97-109. doi: 10.1111/j.1469-1809.2009.00560.x. Epub 2010 Jan 8.

15.

Visualizing disease associations: graphic analysis of frequency distributions as a function of age using moving average plots (MAP) with application to Alzheimer's and Parkinson's disease.

Payami H, Kay DM, Zabetian CP, Schellenberg GD, Factor SA, McCulloch CC.

Genet Epidemiol. 2010 Jan;34(1):92-9. doi: 10.1002/gepi.20439.

16.

Role of the H1 haplotype of microtubule-associated protein tau (MAPT) gene in Greek patients with Parkinson's disease.

Refenes N, Bolbrinker J, Tagaris G, Orlacchio A, Drakoulis N, Kreutz R.

BMC Neurol. 2009 Jun 28;9:26. doi: 10.1186/1471-2377-9-26.

17.

Genomewide association study for susceptibility genes contributing to familial Parkinson disease.

Pankratz N, Wilk JB, Latourelle JC, DeStefano AL, Halter C, Pugh EW, Doheny KF, Gusella JF, Nichols WC, Foroud T, Myers RH; PSG-PROGENI and GenePD Investigators, Coordinators and Molecular Genetic Laboratories.

Hum Genet. 2009 Jan;124(6):593-605. doi: 10.1007/s00439-008-0582-9. Epub 2008 Nov 6.

18.

Replication of association between ELAVL4 and Parkinson disease: the GenePD study.

DeStefano AL, Latourelle J, Lew MF, Suchowersky O, Klein C, Golbe LI, Mark MH, Growdon JH, Wooten GF, Watts R, Guttman M, Racette BA, Perlmutter JS, Marlor L, Shill HA, Singer C, Goldwurm S, Pezzoli G, Saint-Hilaire MH, Hendricks AE, Gower A, Williamson S, Nagle MW, Wilk JB, Massood T, Huskey KW, Baker KB, Itin I, Litvan I, Nicholson G, Corbett A, Nance M, Drasby E, Isaacson S, Burn DJ, Chinnery PF, Pramstaller PP, Al-Hinti J, Moller AT, Ostergaard K, Sherman SJ, Roxburgh R, Snow B, Slevin JT, Cambi F, Gusella JF, Myers RH.

Hum Genet. 2008 Aug;124(1):95-9. doi: 10.1007/s00439-008-0526-4. Epub 2008 Jun 29.

19.

Evidence of shared risk for Alzheimer's disease and Parkinson's disease using family history.

Rosen AR, Steenland NK, Hanfelt J, Factor SA, Lah JJ, Levey AI.

Neurogenetics. 2007 Nov;8(4):263-70. Epub 2007 Sep 6.

20.

Knock-out and transgenic mouse models of tauopathies.

Denk F, Wade-Martins R.

Neurobiol Aging. 2009 Jan;30(1):1-13. Epub 2007 Jun 22. Review.

Items per page

Supplemental Content

Write to the Help Desk